Prognostic Value of Heart‐Type Fatty Acid‐Binding Protein in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 2026 (1)
Abstract
Introduction: Heart‐type fatty acid‐binding protein (H‐FABP) is rapidly released following myocardial injury, but its prognostic significance in acute coronary syndrome (ACS) remains uncertain. We evaluated the association between elevated H‐FABP and adverse clinical outcomes in confirmed or suspected ACS. Methods: PubMed, Embase, CENTRAL, Web of Science and Scopus were searched from inception to 30 August 2026 without date restriction. Studies assessing diagnostic and/or prognostic relevance of circulating H‐FABP in adults with confirmed or suspected ACS were eligible. Prognostic outcomes included all‐cause mortality, major adverse cardiovascular events (MACE), heart failure (HF)–related hospitalisation and recurrent myocardial infarction (MI). Risk of bias was assessed using QUIPS. Crude odds ratios (ORs) from extractable 2 × 2 event data were pooled using inverse‐variance random‐effects models with restricted maximum‐likelihood estimation. Results: Twelve studies were included, with five contributing to meta‐analysis. Elevated H‐FABP was associated with higher odds of all‐cause mortality (OR 5.68; 95% CI 3.98–8.09; I 2 = 30 % ), MACE (OR 4.56; 95% CI 1.97–10.55; I 2 = 47 % ), HF‐related hospitalisation (OR 4.29; 95% CI 2.94–6.26; I 2 = 0 % ) and recurrent MI (OR 1.65; 95% CI 1.15–2.37; I 2 = 0 % ). Pooled estimates were unadjusted; seven studies were synthesised narratively. Conclusion: Elevated H‐FABP is associated with adverse outcomes in ACS, but current evidence does not establish independent prognostic value. Further prospective studies should determine whether H‐FABP adds predictive value beyond established clinical and biochemical risk markers.Keywords
This publication has 20 references indexed in Scilit:
- Serum malondialdehyde levels at admission as a predictor of inhospital mortality in patients with acute coronary syndromeCoronary Artery Disease, 2024
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal, 2023
- Fatty acid-binding proteinsCurrent Opinion in Clinical Nutrition and Metabolic Care, 2019
- Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patientsSaudi Journal of Biological Sciences, 2015
- Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarctionActa Cardiologica, 2011
- Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndromeClinical Research in Cardiology, 2010
- Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-NegativeJACC, 2010
- Prognostic Value of a Multimarker Approach for Patients Presenting to Hospital With Acute Chest PainThe American Journal of Cardiology, 2009
- Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin ValuesJACC, 2007
- Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding proteinQJM: An International Journal of Medicine, 2004